Center for Cancer Nanotechnology Excellence Focused on Therapy Response

2009 Annual CCNE-TR Symposium

Martin McIntosh, Ph.D.
Director, Computational Proteomics Laboratory
Fred Hutchinson Cancer Research Center

Martin McIntosh, Ph.D., is a Full Member at the Fred Hutchinson Cancer Research Center (FHCRC) and Principal Investigator of the Computational Proteomics Laboratory (CPL). Dr. McIntosh has a long history of research in biomarkers and early detection of disease, especially of ovarian cancer. He is the leader of an early detection project of the FHCRC's ovarian cancer SPORE award and is one of three PIs of the NCI's proteomics initiative consortia. Dr. McIntosh is PI of the Early Detection Research Network (EDRN) biomarker development laboratory (for breast and ovarian cancer), and his laboratory leads the data integration and mining for several consortia for cancer as well as neurodegenerative disease research. His primary research focus involves discovery and evaluation of biomarkers and biomarker panels for early disease detection. He is an Associate Editor for the Journal of Proteome Research and co-Chair of the biomarker initiative for the Human Proteome Organization (HUPO). Dr. McIntosh serves in leadership positions both at the FHCRC and nationally for biomarker discovery research programs.

[ Back ]